Press release
Global Bacterial Pneumonia Market to Reach $3.51 Billion by 2029, Growing at 8.7% CAGR
Bacterial Pneumonia
The rising prevalence of respiratory diseases is expected to drive the growth of the bacterial pneumonia market moving forward. Respiratory diseases are conditions that affect the lungs and airway systems, interfering with breathing and gas exchange. The increased prevalence of respiratory diseases is attributed to factors such as environmental influences, lifestyle choices, demographic changes, and genetic predispositions. These diseases heighten the risk of bacterial pneumonia by weakening the immune system and damaging lung tissues, creating an environment for bacterial infections. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported a rise in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. Hence, the growing prevalence of respiratory diseases is driving the bacterial pneumonia market's expansion.
Get Your Bacterial Pneumonia Market Report Here:
https://www.thebusinessresearchcompany.com/report/bacterial-pneumonia-global-market-report
What is the projected compound annual growth rate (CAGR) of the bacterial pneumonia market from 2025 to 2034, and what factors influence it?
The bacterial pneumonia market has grown significantly. It is expected to increase from $2.31 billion in 2024 to $2.52 billion in 2025 at a CAGR of 9.0%. Growth in past years was driven by rising awareness of respiratory diseases, increasing bacterial infections, a growing geriatric population, higher healthcare expenditure, urbanization, and worsening air pollution.
The bacterial pneumonia market size is forecasted to expand significantly, reaching $3.51 billion by 2029 with a CAGR of 8.7%. This growth will be driven by rising tobacco and alcohol consumption, greater government funding and initiatives, an increasing prevalence of respiratory infections, mounting antibiotic resistance, improved healthcare access, and heightened awareness of bacterial pneumonia. Key trends in the forecast period include the introduction of novel antibiotics, widespread adoption of rapid diagnostic tools, progress in vaccine technology, the emergence of personalized medicine, AI integration in disease management, and increased use of monoclonal antibodies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21109&type=smp
How are the latest trends influencing the growth of the bacterial pneumonia market?
In the bacterial pneumonia market, companies are innovating with conjugate vaccines to enhance immune response and efficacy. For example, in June 2024, Merck & Co. Inc., a U.S.-based pharmaceutical company, received FDA approval for CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine). This vaccine targets multiple strains of Streptococcus pneumoniae, offering protection against invasive pneumococcal disease and pneumonia, especially in adults.
What are the major segments of the bacterial pneumonia market and their role in driving growth?
The bacterial pneumonia market covered in this report is segmented -
1) Ву Туре: Community-Acquired Pneumonia (CAP), Hospital-Acquired Pneumonia (HAP)
2) By Route Of Administration: Oral, Subcutaneous, Other Route Of Administration
3) By Treatments: Vaccines, Drugs
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Community-Acquired Pneumonia (CAP): Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila
2) By Hospital-Acquired Pneumonia (HAP): Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Enterobacter spp
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21109
Which regions are key players in the growth of the bacterial pneumonia market?
North America was the largest region in the bacterial pneumonia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bacterial pneumonia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the bacterial pneumonia market?
Major companies operating in the bacterial pneumonia market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca PLC, Novartis AG, GSK plc, bioMerieux SA, Shionogi & Co. Ltd., Wockhardt Limited., Zai Lab Limited, Innoviva Inc., Eagle Pharmaceuticals Inc., Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics Inc., Nabriva Therapeutics plc., Clarametyx Biosciences Inc., Evopoint Biosciences Inc., Vaxcyte Inc., Acurx Pharmaceuticals Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21109&type=smp
What Is Covered In The Bacterial Pneumonia Global Market Report?
•Market Size Forecast: Examine the bacterial pneumonia market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the bacterial pneumonia market for a structured understanding.
•Key Players Overview: Analyze major players in the bacterial pneumonia market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the bacterial pneumonia market.
•Segment Contributions: Evaluate how different segments drive overall growth in the bacterial pneumonia market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the bacterial pneumonia market.
•Industry Challenges: Identify potential risks and obstacles affecting the bacterial pneumonia market.
•Competitive Landscape: Review strategic developments in the bacterial pneumonia market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Bacterial Pneumonia Market to Reach $3.51 Billion by 2029, Growing at 8.7% CAGR here
News-ID: 3936287 • Views: …
More Releases from The Business Research Company
Surgical Retractors Market Trends That Will Shape the Next Decade: Insights from …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Surgical Retractors Market Size By 2025?
The market size for surgical retractors has experienced notable growth over recent years. The market, which was valued at $2.45 billion in 2024, is projected to increase to $2.57 billion in 2025, following a compound annual growth rate (CAGR)…
Transformative Trends Impacting the Cataract Surgery Devices And Equipment Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Cataract Surgery Devices And Equipment Market Size By 2025?
The market size for cataract surgery devices and equipment has shown a consistent growth trend in recent years. It is projected to increase from $13.97 billion in 2024 to $14.52 billion in 2025, exhibiting a compound…
Rising Demand For Minimally Invasive Surgery Drives Growth In Robotic Surgery De …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Robotic Surgery Devices Market Size Growth Forecast: What to Expect by 2025?
The market for robotic surgery devices has experienced a swift expansion in the past years. Its size is projected to increase from $7.84 billion in 2024 to $8.81 billion in 2025, with a compound annual growth rate…
Steady Expansion Forecast for Orthopedic Devices Market, Projected to Reach $61. …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Orthopedic Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of orthopedic devices has witnessed substantial growth in the past few years. The market, which stood at $47.78 billion in 2024, is projected to increase to $50.26 billion in 2025, reflecting a…
More Releases for Pneumonia
Nosocomial pneumonia, which is acquired in hospitals, and pneumonia linked to ve …
Hospital-acquired pneumonia (HAP), also known as nosocomial pneumonia, is a severe lung infection that develops 48 hours or more after hospital admission, often associated with invasive procedures such as mechanical ventilation. It is one of the most common healthcare-associated infections, contributing significantly to morbidity, mortality, and healthcare costs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72903
With the rise of antibiotic resistance, aging populations, and increased use of ventilators in…
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776
Key Market Drivers
• Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market?
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
